Literature DB >> 25381326

Heart failure risk prediction in the Multi-Ethnic Study of Atherosclerosis.

Harjit Chahal1, David A Bluemke2, Colin O Wu3, Robyn McClelland4, Kiang Liu5, Steven J Shea6, Gregory Burke7, Pelbreton Balfour8, David Herrington8, PeiBei Shi3, Wendy Post1, Jean Olson9, Karol E Watson10, Aaron R Folsom11, Joao A C Lima1.   

Abstract

OBJECTIVE: Heart failure (HF) is a leading cause of mortality especially in older populations. Early detection of high-risk individuals is imperative for primary prevention. The purpose of this study was to develop a HF risk model from a population without clinical cardiac disease.
METHODS: The Multi-Ethnic Study of Atherosclerosis is a multicentre observational cohort study following 6814 subjects (mean age 62±10 years; 47% men) who were free of clinical cardiovascular disease at baseline. Median follow-up was 4.7 years. HF events developed in 176 participants. Cox proportional hazards models and regression coefficients were used to determine independent risk factors and generate a 5-year risk score for incident HF. Bootstrapping with bias correction was used for internal validation.
RESULTS: Independent predictors for HF (HR, p value) were age (1.30 (1.10 to 1.50) per 10 years), male gender (2.27 (1.53 to 3.36)), current smoking (1.97 (1.15 to 3.36)), body mass index (1.40 (1.10 to 1.80) per 5 kg/m(2)), systolic blood pressure (1.10 (1.00 to 1.10) per 10 mm Hg), heart rate (1.30) (1.10 to 1.40) per 10 bpm), diabetes (2.27 (1.48 to 3.47)), N-terminal pro-B-type natriuretic peptide (NT proBNP) (2.48 (2.16 to 2.84) per unit log increment) and left ventricular mass index (1.40 (1.30 to 1.40) per 10 g/m(2)). A parsimonious model based on age, gender, body mass index, smoking status, systolic blood pressure, heart rate, diabetes and NT proBNP natriuretic peptide predicted incident HF risk with a c-statistic of 0.87.
CONCLUSIONS: A clinical algorithm based on risk factors readily available in the primary care setting can used to identify individuals with high likelihood of developing HF without pre-existing cardiac disease. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  HEART FAILURE

Mesh:

Year:  2014        PMID: 25381326      PMCID: PMC4685458          DOI: 10.1136/heartjnl-2014-305697

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

1.  Internal and external validation of predictive models: a simulation study of bias and precision in small samples.

Authors:  Ewout W Steyerberg; Sacha E Bleeker; Henriëtte A Moll; Diederick E Grobbee; Karel G M Moons
Journal:  J Clin Epidemiol       Date:  2003-05       Impact factor: 6.437

2.  Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.

Authors:  J Gustav Smith; Christopher Newton-Cheh; Peter Almgren; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Pyotr G Platonov; Bo Hedblad; Gunnar Engström; Thomas J Wang; Olle Melander
Journal:  J Am Coll Cardiol       Date:  2010-11-16       Impact factor: 24.094

3.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2009-12-17       Impact factor: 29.690

4.  Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Aditya Jain; Harikrishna Tandri; Darshan Dalal; Harjit Chahal; Elsayed Z Soliman; Ronald J Prineas; Aaron R Folsom; João A C Lima; David A Bluemke
Journal:  Am Heart J       Date:  2010-04       Impact factor: 4.749

5.  Quantifying discrimination of Framingham risk functions with different survival C statistics.

Authors:  Michael J Pencina; Ralph B D'Agostino; Linye Song
Journal:  Stat Med       Date:  2012-02-17       Impact factor: 2.373

6.  ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America.

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

7.  Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.

Authors:  Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima
Journal:  Arch Intern Med       Date:  2008-10-27

8.  Incident heart failure prediction in the elderly: the health ABC heart failure score.

Authors:  Javed Butler; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Rhonda Belue; Nicolas Rodondi; Melissa Garcia; Douglas C Bauer; Suzanne Satterfield; Andrew L Smith; Viola Vaccarino; Anne B Newman; Tamara B Harris; Peter W F Wilson; Stephen B Kritchevsky
Journal:  Circ Heart Fail       Date:  2008-07       Impact factor: 8.790

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Sunil K Agarwal; Lloyd E Chambless; Christie M Ballantyne; Brad Astor; Alain G Bertoni; Patricia P Chang; Aaron R Folsom; Max He; Ron C Hoogeveen; Hanyu Ni; Pedro M Quibrera; Wayne D Rosamond; Stuart D Russell; Eyal Shahar; Gerardo Heiss
Journal:  Circ Heart Fail       Date:  2012-05-15       Impact factor: 8.790

View more
  33 in total

1.  Right Ventricular Structure and Function Are Associated With Incident Atrial Fibrillation: MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle).

Authors:  Neal A Chatterjee; Ravi V Shah; Venkatesh L Murthy; Amy Praestgaard; Sanjiv J Shah; Corey E Ventetuolo; R Graham Barr; Richard Kronmal; Joao A C Lima; David A Bluemke; Michael Jerosch-Herold; Alvaro Alonso; Steven M Kawut
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-01

2.  Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study.

Authors:  Ambarish Pandey; Neil Keshvani; Colby Ayers; Adolfo Correa; Mark H Drazner; Alana Lewis; Carlos J Rodriguez; Michael E Hall; Ervin R Fox; Robert J Mentz; Christopher deFilippi; Stephen L Seliger; Christie M Ballantyne; Ian J Neeland; James A de Lemos; Jarett D Berry
Journal:  JAMA Cardiol       Date:  2019-01-01       Impact factor: 14.676

3.  Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.

Authors:  Daniel Edmonston; Daniel Wojdyla; Rupal Mehta; Xuan Cai; Claudia Lora; Debbie Cohen; Raymond R Townsend; Jiang He; Alan S Go; John Kusek; Matthew R Weir; Tamara Isakova; Michael Pencina; Myles Wolf
Journal:  Am J Kidney Dis       Date:  2019-08-21       Impact factor: 8.860

4.  Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure.

Authors:  Abdullahi O Oseni; Waqas T Qureshi; Mohamed F Almahmoud; Alain G Bertoni; David A Bluemke; William G Hundley; Joao A C Lima; David M Herrington; Elsayed Z Soliman
Journal:  Heart       Date:  2016-08-02       Impact factor: 5.994

5.  Clinical characteristics of HIV-infected patients with adjudicated heart failure.

Authors:  Alexandra B Steverson; Anna E Pawlowski; Daniel Schneider; Prasanth Nannapaneni; Jes M Sanders; Chad J Achenbach; Sanjiv J Shah; Donald M Lloyd-Jones; Matthew J Feinstein
Journal:  Eur J Prev Cardiol       Date:  2017-09-25       Impact factor: 7.804

6.  Global Nature of Incipient Chamber Remodeling and Dysfunction in Diabetic Individuals Living in the Community: Potential Mechanisms.

Authors:  Eric Xie; João A C Lima
Journal:  Circ Cardiovasc Imaging       Date:  2019-09-16       Impact factor: 7.792

7.  Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies.

Authors:  Janice M Bonsu; Avirup Guha; Lawrence Charles; Vedat O Yildiz; Lai Wei; Brandee Baker; Jonathan E Brammer; Farrukh Awan; Maryam Lustberg; Raquel Reinbolt; Eric D Miller; Hani Jneid; Patrick Ruz; Rebecca R Carter; Michael W Milks; Electra D Paskett; Daniel Addison
Journal:  J Am Coll Cardiol       Date:  2020-02-18       Impact factor: 24.094

8.  Association of Elevated NT-proBNP With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Chia-Ying Liu; Susan R Heckbert; Shenghan Lai; Bharath Ambale-Venkatesh; Mohammad R Ostovaneh; Robyn L McClelland; João A C Lima; David A Bluemke
Journal:  J Am Coll Cardiol       Date:  2017-12-26       Impact factor: 24.094

9.  Association of the Novel Inflammatory Marker GlycA and Incident Heart Failure and Its Subtypes of Preserved and Reduced Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Sunyoung Jang; Oluseye Ogunmoroti; Chiadi E Ndumele; Di Zhao; Vishal N Rao; Oluwaseun E Fashanu; Martin Tibuakuu; James D Otvos; Eve-Marie Benson; Pamela Ouyang; Erin D Michos
Journal:  Circ Heart Fail       Date:  2020-07-28       Impact factor: 8.790

10.  Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes.

Authors:  Jennifer E Ho; Danielle Enserro; Frank P Brouwers; Jorge R Kizer; Sanjiv J Shah; Bruce M Psaty; Traci M Bartz; Rajalakshmi Santhanakrishnan; Douglas S Lee; Cheeling Chan; Kiang Liu; Michael J Blaha; Hans L Hillege; Pim van der Harst; Wiek H van Gilst; Willem J Kop; Ron T Gansevoort; Ramachandran S Vasan; Julius M Gardin; Daniel Levy; John S Gottdiener; Rudolf A de Boer; Martin G Larson
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.